On January 31, 2022, DMC Biotechnologies, Inc. closed the transaction. The transaction included participation from Conti Ventures of Continental Grain Company Corp. and Toyobo Co., Ltd.
DMC Biotechnologies, Inc. announced that it has received $39 million in funding from a group of investors
Published on 01/30/2022 at 18:00
S&P Capital IQ
Share
© S&P Capital IQ - 2022
Share